Management change at Actelion
Roland will hand over his position to Andrew Weiss, who joins Actelion from Bank Vontobel, where he was Head of Life Science Equity Research / Pharma Analyst.
Jean-Paul Clozel M.D. and Chief Executive Officer commented: "I am very pleased to welcome Andrew Weiss to Actelion as new Head of IR & CC and member of the Extended AEC. He brings an excellent understanding of the pharmaceutical market and a deep experience of the financial community. I am convinced that with his background and skills he will contribute to the future success of Actelion."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.